There Are 8 Billion Reasons to Buy Rocket Lab At $50

Published November 18, 2026, 8:45am ET · 3 min read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

A white rocket with a bright orange exhaust flame and smoke trail ascends diagonally against a deep navy blue sky.
A SpaceX rocket launches into the sky, symbolizing the company's anticipated surge in the market. This powerful visual reflects growing investor enthusiasm ahead of its Nasdaq-100 inclusion. © Public Domain / Wikimedia Commons

Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) draws closer scrutiny near $50, and the stock currently trades at $55.05, within reach of that level. A record $3.57 billion[1] backlog plus $4.45 billion in cash adds up to roughly $8.02 billion of contracted revenue and liquidity behind a $34.79 billion company.

Rocket Lab flies the Electron small-lift rocket and the HASTE hypersonic test vehicle, is developing the reusable Neutron medium-lift rocket, and builds spacecraft and components through Space Systems. A pending acquisition of Iridium Communications (NASDAQ:IRDM) would add an operating satellite constellation. Shares sat at $84.16[2] when first-quarter results landed, then fell after Neutron’s debut was delayed to no earlier than 2027[1].

Neutron Bookings Signal Launch Demand Is Outrunning Supply

Third-quarter revenue reached $267.83 million[1], up 72.7% year over year and ahead of the $257.18 million consensus. Backlog jumped 52% sequentially[3] on nearly $1 billion[1] in new launch contracts. Neutron has 16 launches booked[3] at a base price raised to $70 million, with the next open slots in the 2030s. CFO Adam Spice said, “We chose to go for higher ASP and lower volumes.”[3]

Defense work strengthens the moat: a Golden Dome Space Based Interceptor selection alongside Raytheon, an $816 million[4] SDA Tracking Layer contract, and a $397 million Space Force award.

Losses, Dilution and Delays Weigh on Shares

Third-quarter GAAP EPS of -$0.12[1] missed the -$0.0665 consensus, and the net loss grew to $79.68 million. Non-GAAP gross margin was delayed to 38.4% from 41.9%. Funding Iridium required issuing 36.8 million shares[3], and the stock trades at 47 times trailing sales.

Neutron has was delayed repeatedly. CEO Peter Beck declined to give a launch quarter: “I just don’t want to be continually wrong.”[3] Fiscal 2026 EPS consensus has slipped to -$0.3077 from -$0.2660 90 days ago.

Neutron’s First Flight Decides the Next Leg

Management expects adjusted EBITDA to turn positive within about six months[3] of a successful Neutron test flight, so the date of that flight determines the profit timeline. Iridium still awaits final regulatory approvals. Fourth-quarter guidance calls for $270 million to $290 million[1] in revenue alongside an adjusted EBITDA loss of $14 million to $20 million. Tank qualification results and the Iridium close are the next milestones to track.

Analysts See 69% Upside Despite a Lagging Year

The consensus target of $93.10 implies 69.1% upside from current levels and 86.2% from $50. Targets are one data point, and they shift with views. Of 22 analysts:

  • Strong Buy: 5
  • Buy: 13
  • Hold: 4
  • Sell: 0

Rocket Lab is down 21.09% year to date while the S&P 500 gained 7.37%. Over one year, it rose 27.11% against the index’s 9.99%. A beta of 3.176 means swings run large in both directions.

Rocket Lab’s Case Strengthens at $50

At $50, the valuation gap to the analyst consensus target grew.

Roughly 32.9%[3] of backlog converts to revenue within 12 months, and the cash pile supports continued Neutron development. Spice described Neutron contracts as carrying “real deposits”[3] and cancellation fees, which makes that backlog firmer than options.

The path higher runs through three drivers over the next 12 to 18 months: the Iridium close, Electron and HASTE execution, and Neutron’s first flight. Each converts the backlog into margin. A further Neutron slip past 2027 or a failed debut would invalidate the thesis.

At $50, the stock would be backed by $8 billion in visible demand and cash for a company whose biggest drivers has yet to fly.

Contact [email protected] for any questions or corrections.

Alex Sirois

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

All articles →

Sources

  1. Rocket Lab Form 8-K (Q3 FY2026)U.S. Securities and Exchange Commission
  2. Rocket Lab Form 8-K (Q1 FY2026)U.S. Securities and Exchange Commission
  3. Rocket Lab Corporation Q3 2026 earnings callRocket Lab Corporation
  4. Rocket Lab Form 8-K (Q4 FY2025)U.S. Securities and Exchange Commission